SpyGlass Pharma Inc
NASDAQ:SGP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
SpyGlass Pharma Inc (SGP) under the Base Case is 1.21 USD per share.
Compared with the current market price of 32.88 USD, the stock appears
Overvalued by 96% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What SpyGlass Pharma Does
SpyGlass Pharma develops eye-treatment products that are designed to deliver medicine inside the eye over a long period of time. Its core idea is to replace frequent eye drops with a small implant or drug-delivery device that an ophthalmologist can place during a routine eye procedure, especially for people being treated for glaucoma or eye pressure control.
- Headquarters
- United States of America US
- Employees
- 65
- IPO date
- Feb 6, 2026
Earnings Waterfall
SpyGlass Pharma Inc
Continue SGP Research
Decided on SpyGlass Pharma? Get an email when SGP reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one SGP stock?
The intrinsic value for
SpyGlass Pharma Inc (SGP) under the Base Case is 1.21 USD.
Is SGP stock undervalued or overvalued?
Compared with the current market price of 32.88 USD, the stock appears Overvalued by 96% .